GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ERG
|
ENSG00000157554.14 | ETS transcription factor ERG |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ERG | hg19_v2_chr21_-_40033618_40033712, hg19_v2_chr21_-_39870339_39870443 | 0.30 | 4.6e-06 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr21_-_46340770 | 33.98 |
ENST00000397854.3
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr5_-_130970723 | 26.74 |
ENST00000308008.6
ENST00000296859.6 ENST00000507093.1 ENST00000510071.1 ENST00000509018.1 ENST00000307984.5 |
RAPGEF6
|
Rap guanine nucleotide exchange factor (GEF) 6 |
chr1_+_153330322 | 26.04 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
chr11_+_1874200 | 25.88 |
ENST00000311604.3
|
LSP1
|
lymphocyte-specific protein 1 |
chr6_+_33048222 | 25.58 |
ENST00000428835.1
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr3_-_121379739 | 25.17 |
ENST00000428394.2
ENST00000314583.3 |
HCLS1
|
hematopoietic cell-specific Lyn substrate 1 |
chr21_-_46340884 | 25.14 |
ENST00000302347.5
ENST00000517819.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr19_-_51875894 | 24.11 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
chr1_-_153518270 | 21.08 |
ENST00000354332.4
ENST00000368716.4 |
S100A4
|
S100 calcium binding protein A4 |
chr3_-_128879875 | 19.85 |
ENST00000418265.1
ENST00000393292.3 ENST00000273541.8 |
ISY1-RAB43
ISY1
|
ISY1-RAB43 readthrough ISY1 splicing factor homolog (S. cerevisiae) |
chr1_+_10003486 | 19.64 |
ENST00000403197.1
ENST00000377205.1 |
NMNAT1
|
nicotinamide nucleotide adenylyltransferase 1 |
chr6_+_31553901 | 19.60 |
ENST00000418507.2
ENST00000438075.2 ENST00000376100.3 ENST00000376111.4 |
LST1
|
leukocyte specific transcript 1 |
chr11_-_71791518 | 19.22 |
ENST00000537217.1
ENST00000366394.3 ENST00000358965.6 ENST00000546131.1 ENST00000543937.1 ENST00000368959.5 ENST00000541641.1 |
NUMA1
|
nuclear mitotic apparatus protein 1 |
chr11_+_2421718 | 19.11 |
ENST00000380996.5
ENST00000333256.6 ENST00000380992.1 ENST00000437110.1 ENST00000435795.1 |
TSSC4
|
tumor suppressing subtransferable candidate 4 |
chr10_-_72362515 | 18.83 |
ENST00000373209.2
ENST00000441259.1 |
PRF1
|
perforin 1 (pore forming protein) |
chr11_+_313503 | 18.19 |
ENST00000528780.1
ENST00000328221.5 |
IFITM1
|
interferon induced transmembrane protein 1 |
chr11_-_71791726 | 18.01 |
ENST00000393695.3
|
NUMA1
|
nuclear mitotic apparatus protein 1 |
chr12_-_6798616 | 17.99 |
ENST00000355772.4
ENST00000417772.3 ENST00000396801.3 ENST00000396799.2 |
ZNF384
|
zinc finger protein 384 |
chr11_-_71791435 | 17.75 |
ENST00000351960.6
ENST00000541719.1 ENST00000535111.1 |
NUMA1
|
nuclear mitotic apparatus protein 1 |
chr6_-_33048483 | 17.63 |
ENST00000419277.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr6_-_33267101 | 17.63 |
ENST00000497454.1
|
RGL2
|
ral guanine nucleotide dissociation stimulator-like 2 |
chr11_-_64512273 | 16.95 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr19_-_36399149 | 16.92 |
ENST00000585901.2
ENST00000544690.2 ENST00000424586.3 ENST00000262629.4 ENST00000589517.1 |
TYROBP
|
TYRO protein tyrosine kinase binding protein |
chr8_-_21771214 | 16.57 |
ENST00000276420.4
|
DOK2
|
docking protein 2, 56kDa |
chr2_+_17935383 | 16.54 |
ENST00000524465.1
ENST00000381254.2 ENST00000532257.1 |
GEN1
|
GEN1 Holliday junction 5' flap endonuclease |
chr5_-_172198190 | 16.42 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
chr12_-_6798523 | 16.25 |
ENST00000319770.3
|
ZNF384
|
zinc finger protein 384 |
chr1_+_156698234 | 16.19 |
ENST00000368218.4
ENST00000368216.4 |
RRNAD1
|
ribosomal RNA adenine dimethylase domain containing 1 |
chr19_-_10450287 | 15.92 |
ENST00000589261.1
ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3
|
intercellular adhesion molecule 3 |
chr22_-_17680472 | 15.86 |
ENST00000330232.4
|
CECR1
|
cat eye syndrome chromosome region, candidate 1 |
chr17_-_76123101 | 15.80 |
ENST00000392467.3
|
TMC6
|
transmembrane channel-like 6 |
chr6_+_31553978 | 15.79 |
ENST00000376096.1
ENST00000376099.1 ENST00000376110.3 |
LST1
|
leukocyte specific transcript 1 |
chr12_+_69742121 | 15.63 |
ENST00000261267.2
ENST00000549690.1 ENST00000548839.1 |
LYZ
|
lysozyme |
chr1_-_25558984 | 15.48 |
ENST00000236273.4
|
SYF2
|
SYF2 pre-mRNA-splicing factor |
chr11_+_71791849 | 15.30 |
ENST00000423494.2
ENST00000539587.1 ENST00000538478.1 ENST00000324866.7 ENST00000439209.1 |
LRTOMT
|
leucine rich transmembrane and O-methyltransferase domain containing |
chr19_-_10450328 | 15.27 |
ENST00000160262.5
|
ICAM3
|
intercellular adhesion molecule 3 |
chr17_-_62097927 | 15.17 |
ENST00000578313.1
ENST00000584084.1 ENST00000579788.1 ENST00000579687.1 ENST00000578379.1 ENST00000578892.1 ENST00000412356.1 ENST00000418105.1 |
ICAM2
|
intercellular adhesion molecule 2 |
chr8_+_117778736 | 14.90 |
ENST00000309822.2
ENST00000357148.3 ENST00000517814.1 ENST00000517820.1 |
UTP23
|
UTP23, small subunit (SSU) processome component, homolog (yeast) |
chr20_-_48532019 | 14.89 |
ENST00000289431.5
|
SPATA2
|
spermatogenesis associated 2 |
chr6_+_111580508 | 14.77 |
ENST00000368847.4
|
KIAA1919
|
KIAA1919 |
chr11_-_46722117 | 14.68 |
ENST00000311956.4
|
ARHGAP1
|
Rho GTPase activating protein 1 |
chr12_-_6798410 | 14.67 |
ENST00000361959.3
ENST00000436774.2 ENST00000544482.1 |
ZNF384
|
zinc finger protein 384 |
chr1_-_36937075 | 14.66 |
ENST00000464465.2
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
chr11_+_46722368 | 14.66 |
ENST00000311764.2
|
ZNF408
|
zinc finger protein 408 |
chr2_-_136873735 | 14.62 |
ENST00000409817.1
|
CXCR4
|
chemokine (C-X-C motif) receptor 4 |
chr12_+_7055767 | 14.52 |
ENST00000447931.2
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr2_+_103035102 | 14.43 |
ENST00000264260.2
|
IL18RAP
|
interleukin 18 receptor accessory protein |
chr11_+_71791693 | 14.32 |
ENST00000289488.2
ENST00000447974.1 |
LRTOMT
|
leucine rich transmembrane and O-methyltransferase domain containing |
chr19_+_1077393 | 14.30 |
ENST00000590577.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr19_+_58694396 | 14.28 |
ENST00000326804.4
ENST00000345813.3 ENST00000424679.2 |
ZNF274
|
zinc finger protein 274 |
chr16_+_30483962 | 14.28 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr3_-_15469006 | 14.27 |
ENST00000443029.1
ENST00000383790.3 ENST00000383789.5 |
METTL6
|
methyltransferase like 6 |
chr3_-_48936272 | 14.26 |
ENST00000544097.1
ENST00000430379.1 ENST00000319017.4 |
SLC25A20
|
solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 |
chr5_+_67584174 | 14.17 |
ENST00000320694.8
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
chrY_+_2709906 | 14.06 |
ENST00000430575.1
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1 |
chr17_-_37844267 | 13.97 |
ENST00000579146.1
ENST00000378011.4 ENST00000429199.2 ENST00000300658.4 |
PGAP3
|
post-GPI attachment to proteins 3 |
chr6_+_31620191 | 13.96 |
ENST00000375918.2
ENST00000375920.4 |
APOM
|
apolipoprotein M |
chr11_-_64885111 | 13.81 |
ENST00000528598.1
ENST00000310597.4 |
ZNHIT2
|
zinc finger, HIT-type containing 2 |
chr19_-_56632592 | 13.75 |
ENST00000587279.1
ENST00000270459.3 |
ZNF787
|
zinc finger protein 787 |
chr1_+_161185032 | 13.58 |
ENST00000367992.3
ENST00000289902.1 |
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
chr12_-_6233828 | 13.57 |
ENST00000572068.1
ENST00000261405.5 |
VWF
|
von Willebrand factor |
chr2_-_96811170 | 13.55 |
ENST00000288943.4
|
DUSP2
|
dual specificity phosphatase 2 |
chr19_+_16296191 | 13.43 |
ENST00000589852.1
ENST00000263384.7 ENST00000588367.1 ENST00000587351.1 |
FAM32A
|
family with sequence similarity 32, member A |
chr1_+_156698708 | 13.43 |
ENST00000519086.1
|
RRNAD1
|
ribosomal RNA adenine dimethylase domain containing 1 |
chrY_+_2709527 | 13.32 |
ENST00000250784.8
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1 |
chr12_-_15114603 | 13.27 |
ENST00000228945.4
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr20_-_4795747 | 13.22 |
ENST00000379376.2
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2 |
chr19_+_56186557 | 13.04 |
ENST00000270460.6
|
EPN1
|
epsin 1 |
chr17_-_62084241 | 13.02 |
ENST00000449662.2
|
ICAM2
|
intercellular adhesion molecule 2 |
chr15_+_71185148 | 12.90 |
ENST00000443425.2
ENST00000560755.1 |
LRRC49
|
leucine rich repeat containing 49 |
chr12_+_7055631 | 12.87 |
ENST00000543115.1
ENST00000399448.1 |
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr14_+_100594914 | 12.86 |
ENST00000554695.1
|
EVL
|
Enah/Vasp-like |
chrX_-_107018969 | 12.79 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
chr17_+_72462766 | 12.77 |
ENST00000392625.3
ENST00000361933.3 ENST00000310828.5 |
CD300A
|
CD300a molecule |
chr11_-_59950622 | 12.71 |
ENST00000323961.3
ENST00000412309.2 |
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A |
chr3_-_18480260 | 12.67 |
ENST00000454909.2
|
SATB1
|
SATB homeobox 1 |
chr4_+_153701081 | 12.62 |
ENST00000451320.2
ENST00000429148.2 ENST00000353617.2 ENST00000405727.2 ENST00000356064.3 |
ARFIP1
|
ADP-ribosylation factor interacting protein 1 |
chr17_-_29641084 | 12.60 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
chr17_-_29641104 | 12.42 |
ENST00000577894.1
ENST00000330927.4 |
EVI2B
|
ecotropic viral integration site 2B |
chr22_+_23247030 | 12.35 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr7_-_76829125 | 12.22 |
ENST00000248598.5
|
FGL2
|
fibrinogen-like 2 |
chr4_+_2814011 | 12.19 |
ENST00000502260.1
ENST00000435136.2 |
SH3BP2
|
SH3-domain binding protein 2 |
chr1_-_20834586 | 12.18 |
ENST00000264198.3
|
MUL1
|
mitochondrial E3 ubiquitin protein ligase 1 |
chr14_-_81687197 | 12.04 |
ENST00000553612.1
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr14_+_100842735 | 11.94 |
ENST00000554998.1
ENST00000402312.3 ENST00000335290.6 ENST00000554175.1 |
WDR25
|
WD repeat domain 25 |
chr22_+_17565841 | 11.93 |
ENST00000319363.6
|
IL17RA
|
interleukin 17 receptor A |
chr12_-_15114492 | 11.89 |
ENST00000541546.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr17_-_62097904 | 11.87 |
ENST00000583366.1
|
ICAM2
|
intercellular adhesion molecule 2 |
chr14_+_100531615 | 11.80 |
ENST00000392920.3
|
EVL
|
Enah/Vasp-like |
chr14_-_81687575 | 11.77 |
ENST00000434192.2
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr19_+_47759716 | 11.75 |
ENST00000221922.6
|
CCDC9
|
coiled-coil domain containing 9 |
chr22_-_37640456 | 11.71 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr16_-_31214051 | 11.57 |
ENST00000350605.4
|
PYCARD
|
PYD and CARD domain containing |
chr22_+_23165153 | 11.50 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr17_+_1674982 | 11.44 |
ENST00000572048.1
ENST00000573763.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr19_+_55141861 | 11.42 |
ENST00000396327.3
ENST00000324602.7 ENST00000434867.2 |
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr1_-_111746966 | 11.41 |
ENST00000369752.5
|
DENND2D
|
DENN/MADD domain containing 2D |
chr15_+_71184931 | 11.40 |
ENST00000560369.1
ENST00000260382.5 |
LRRC49
|
leucine rich repeat containing 49 |
chr10_+_75545391 | 11.33 |
ENST00000604524.1
ENST00000605216.1 ENST00000398706.2 |
ZSWIM8
|
zinc finger, SWIM-type containing 8 |
chr11_-_417308 | 11.32 |
ENST00000397632.3
ENST00000382520.2 |
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr14_-_94856987 | 11.30 |
ENST00000449399.3
ENST00000404814.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr1_-_167487808 | 11.27 |
ENST00000392122.3
|
CD247
|
CD247 molecule |
chr19_+_40854559 | 11.12 |
ENST00000598962.1
ENST00000409419.1 ENST00000409587.1 ENST00000602131.1 ENST00000409735.4 ENST00000600948.1 ENST00000356508.5 ENST00000596682.1 ENST00000594908.1 |
PLD3
|
phospholipase D family, member 3 |
chr16_+_30484021 | 11.12 |
ENST00000358164.5
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr15_+_74833518 | 11.10 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
chr1_+_209929377 | 11.00 |
ENST00000400959.3
ENST00000367025.3 |
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr3_+_47324424 | 10.97 |
ENST00000437353.1
ENST00000232766.5 ENST00000455924.2 |
KLHL18
|
kelch-like family member 18 |
chr14_+_92980111 | 10.96 |
ENST00000216487.7
ENST00000557762.1 |
RIN3
|
Ras and Rab interactor 3 |
chr14_-_24711865 | 10.95 |
ENST00000399423.4
ENST00000267415.7 |
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2 |
chr15_+_77287426 | 10.92 |
ENST00000558012.1
ENST00000267939.5 ENST00000379595.3 |
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1 |
chr1_+_198608146 | 10.87 |
ENST00000367376.2
ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
chr10_+_75545329 | 10.86 |
ENST00000604729.1
ENST00000603114.1 |
ZSWIM8
|
zinc finger, SWIM-type containing 8 |
chr17_-_79269067 | 10.85 |
ENST00000288439.5
ENST00000374759.3 |
SLC38A10
|
solute carrier family 38, member 10 |
chr14_-_94857004 | 10.84 |
ENST00000557492.1
ENST00000448921.1 ENST00000437397.1 ENST00000355814.4 ENST00000393088.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr20_+_62612470 | 10.83 |
ENST00000266079.4
ENST00000535781.1 |
PRPF6
|
pre-mRNA processing factor 6 |
chr14_-_94856951 | 10.76 |
ENST00000553327.1
ENST00000556955.1 ENST00000557118.1 ENST00000440909.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr11_-_60719213 | 10.69 |
ENST00000227880.3
|
SLC15A3
|
solute carrier family 15 (oligopeptide transporter), member 3 |
chr14_+_24583836 | 10.66 |
ENST00000559115.1
ENST00000558215.1 ENST00000557810.1 ENST00000561375.1 ENST00000446197.3 ENST00000559796.1 ENST00000560713.1 ENST00000560901.1 ENST00000559382.1 |
DCAF11
|
DDB1 and CUL4 associated factor 11 |
chr2_-_69870747 | 10.65 |
ENST00000409068.1
|
AAK1
|
AP2 associated kinase 1 |
chr1_-_183559693 | 10.64 |
ENST00000367535.3
ENST00000413720.1 ENST00000418089.1 |
NCF2
|
neutrophil cytosolic factor 2 |
chr1_+_228353495 | 10.64 |
ENST00000366711.3
|
IBA57
|
IBA57, iron-sulfur cluster assembly homolog (S. cerevisiae) |
chr1_+_209929494 | 10.63 |
ENST00000367026.3
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr5_-_180236811 | 10.63 |
ENST00000446023.2
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
chr11_-_417388 | 10.58 |
ENST00000332725.3
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr1_+_1260147 | 10.57 |
ENST00000343938.4
|
GLTPD1
|
glycolipid transfer protein domain containing 1 |
chr1_-_167487758 | 10.55 |
ENST00000362089.5
|
CD247
|
CD247 molecule |
chr14_+_75746781 | 10.54 |
ENST00000555347.1
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr14_-_24711806 | 10.53 |
ENST00000540705.1
ENST00000538777.1 ENST00000558566.1 ENST00000559019.1 |
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2 |
chr11_-_59950519 | 10.48 |
ENST00000528851.1
|
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A |
chr8_-_21771182 | 10.46 |
ENST00000523932.1
ENST00000544659.1 |
DOK2
|
docking protein 2, 56kDa |
chr4_-_156875003 | 10.45 |
ENST00000433477.3
|
CTSO
|
cathepsin O |
chr2_+_54198210 | 10.43 |
ENST00000607452.1
ENST00000422521.2 |
ACYP2
|
acylphosphatase 2, muscle type |
chr20_-_44993012 | 10.34 |
ENST00000372229.1
ENST00000372230.5 ENST00000543605.1 ENST00000243896.2 ENST00000317734.8 |
SLC35C2
|
solute carrier family 35 (GDP-fucose transporter), member C2 |
chr7_+_150264365 | 10.30 |
ENST00000255945.2
ENST00000461940.1 |
GIMAP4
|
GTPase, IMAP family member 4 |
chr1_-_150738261 | 10.26 |
ENST00000448301.2
ENST00000368985.3 |
CTSS
|
cathepsin S |
chr20_+_49575342 | 10.23 |
ENST00000244051.1
|
MOCS3
|
molybdenum cofactor synthesis 3 |
chr1_-_183560011 | 10.23 |
ENST00000367536.1
|
NCF2
|
neutrophil cytosolic factor 2 |
chr6_-_112080256 | 10.23 |
ENST00000462856.2
ENST00000229471.4 |
FYN
|
FYN oncogene related to SRC, FGR, YES |
chr11_-_59950486 | 10.19 |
ENST00000426738.2
ENST00000533023.1 ENST00000420732.2 |
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A |
chr11_-_64512803 | 10.18 |
ENST00000377489.1
ENST00000354024.3 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr5_-_131892501 | 10.16 |
ENST00000450655.1
|
IL5
|
interleukin 5 (colony-stimulating factor, eosinophil) |
chr17_-_18218237 | 10.12 |
ENST00000542570.1
|
TOP3A
|
topoisomerase (DNA) III alpha |
chr22_+_22020273 | 10.12 |
ENST00000412327.1
ENST00000335025.8 ENST00000398831.3 ENST00000492445.2 ENST00000458567.1 ENST00000406385.1 |
PPIL2
|
peptidylprolyl isomerase (cyclophilin)-like 2 |
chr17_+_4843679 | 10.11 |
ENST00000576229.1
|
RNF167
|
ring finger protein 167 |
chr3_+_15468862 | 10.10 |
ENST00000396842.2
|
EAF1
|
ELL associated factor 1 |
chr17_-_18218270 | 10.06 |
ENST00000321105.5
|
TOP3A
|
topoisomerase (DNA) III alpha |
chr1_+_32716840 | 10.06 |
ENST00000336890.5
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr19_+_56186606 | 10.04 |
ENST00000085079.7
|
EPN1
|
epsin 1 |
chrX_+_128913906 | 9.94 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
chr22_-_38245304 | 9.86 |
ENST00000609454.1
|
ANKRD54
|
ankyrin repeat domain 54 |
chr1_-_153517473 | 9.82 |
ENST00000368715.1
|
S100A4
|
S100 calcium binding protein A4 |
chr19_+_50879705 | 9.80 |
ENST00000598168.1
ENST00000411902.2 ENST00000253727.5 ENST00000597790.1 ENST00000597130.1 ENST00000599105.1 |
NR1H2
|
nuclear receptor subfamily 1, group H, member 2 |
chr7_+_156742399 | 9.78 |
ENST00000275820.3
|
NOM1
|
nucleolar protein with MIF4G domain 1 |
chr16_-_88717482 | 9.77 |
ENST00000261623.3
|
CYBA
|
cytochrome b-245, alpha polypeptide |
chr1_+_24969755 | 9.74 |
ENST00000447431.2
ENST00000374389.4 |
SRRM1
|
serine/arginine repetitive matrix 1 |
chr12_-_51717948 | 9.73 |
ENST00000267012.4
|
BIN2
|
bridging integrator 2 |
chr21_+_45432174 | 9.72 |
ENST00000380221.3
ENST00000291574.4 |
TRAPPC10
|
trafficking protein particle complex 10 |
chr1_+_169337172 | 9.71 |
ENST00000367807.3
ENST00000367808.3 ENST00000329281.2 ENST00000420531.1 |
BLZF1
|
basic leucine zipper nuclear factor 1 |
chr12_-_51717875 | 9.69 |
ENST00000604560.1
|
BIN2
|
bridging integrator 2 |
chr11_+_5710919 | 9.68 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
chr2_-_238322770 | 9.68 |
ENST00000472056.1
|
COL6A3
|
collagen, type VI, alpha 3 |
chr20_-_35580240 | 9.64 |
ENST00000262878.4
|
SAMHD1
|
SAM domain and HD domain 1 |
chr12_+_9102632 | 9.62 |
ENST00000539240.1
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1 |
chr19_+_48248779 | 9.60 |
ENST00000246802.5
|
GLTSCR2
|
glioma tumor suppressor candidate region gene 2 |
chr3_+_122044084 | 9.58 |
ENST00000264474.3
ENST00000479204.1 |
CSTA
|
cystatin A (stefin A) |
chr4_-_926069 | 9.58 |
ENST00000314167.4
ENST00000502656.1 |
GAK
|
cyclin G associated kinase |
chr18_-_47813940 | 9.51 |
ENST00000586837.1
ENST00000412036.2 ENST00000589940.1 |
CXXC1
|
CXXC finger protein 1 |
chr13_-_46756351 | 9.50 |
ENST00000323076.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr3_-_101232019 | 9.49 |
ENST00000394095.2
ENST00000394091.1 ENST00000394094.2 ENST00000358203.3 ENST00000348610.3 ENST00000314261.7 |
SENP7
|
SUMO1/sentrin specific peptidase 7 |
chr7_+_108210012 | 9.48 |
ENST00000249356.3
|
DNAJB9
|
DnaJ (Hsp40) homolog, subfamily B, member 9 |
chr1_-_160001737 | 9.45 |
ENST00000368090.2
|
PIGM
|
phosphatidylinositol glycan anchor biosynthesis, class M |
chr21_-_38639601 | 9.40 |
ENST00000539844.1
ENST00000476950.1 ENST00000399001.1 |
DSCR3
|
Down syndrome critical region gene 3 |
chr11_-_62389449 | 9.40 |
ENST00000534026.1
|
B3GAT3
|
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
chr8_-_134309823 | 9.37 |
ENST00000414097.2
|
NDRG1
|
N-myc downstream regulated 1 |
chr19_+_55141948 | 9.36 |
ENST00000396332.4
ENST00000427581.2 |
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr2_-_238322800 | 9.35 |
ENST00000392004.3
ENST00000433762.1 ENST00000347401.3 ENST00000353578.4 ENST00000346358.4 ENST00000392003.2 |
COL6A3
|
collagen, type VI, alpha 3 |
chr8_+_38585704 | 9.33 |
ENST00000519416.1
ENST00000520615.1 |
TACC1
|
transforming, acidic coiled-coil containing protein 1 |
chr12_-_51717922 | 9.32 |
ENST00000452142.2
|
BIN2
|
bridging integrator 2 |
chr17_+_4843654 | 9.31 |
ENST00000575111.1
|
RNF167
|
ring finger protein 167 |
chr5_-_39274617 | 9.30 |
ENST00000510188.1
|
FYB
|
FYN binding protein |
chr20_-_23066953 | 9.30 |
ENST00000246006.4
|
CD93
|
CD93 molecule |
chr2_+_69001913 | 9.30 |
ENST00000409030.3
ENST00000409220.1 |
ARHGAP25
|
Rho GTPase activating protein 25 |
chr19_+_49838653 | 9.24 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr8_+_144373550 | 9.24 |
ENST00000330143.3
ENST00000521537.1 ENST00000518432.1 ENST00000520333.1 |
ZNF696
|
zinc finger protein 696 |
chr14_+_23299088 | 9.22 |
ENST00000355151.5
ENST00000397496.3 ENST00000555345.1 ENST00000432849.3 ENST00000553711.1 ENST00000556465.1 ENST00000397505.2 ENST00000557221.1 ENST00000311892.6 ENST00000556840.1 ENST00000555536.1 |
MRPL52
|
mitochondrial ribosomal protein L52 |
chr11_-_61129335 | 9.19 |
ENST00000545361.1
ENST00000539128.1 ENST00000546151.1 ENST00000447532.2 |
CYB561A3
|
cytochrome b561 family, member A3 |
chr15_+_75074410 | 9.18 |
ENST00000439220.2
|
CSK
|
c-src tyrosine kinase |
chr19_+_18942761 | 9.15 |
ENST00000599848.1
|
UPF1
|
UPF1 regulator of nonsense transcripts homolog (yeast) |
chr22_+_37257015 | 9.09 |
ENST00000447071.1
ENST00000248899.6 ENST00000397147.4 |
NCF4
|
neutrophil cytosolic factor 4, 40kDa |
chr18_-_47807829 | 9.05 |
ENST00000585672.1
ENST00000457839.2 ENST00000353909.3 ENST00000339998.6 ENST00000398493.1 |
MBD1
|
methyl-CpG binding domain protein 1 |
chr17_-_79818354 | 9.04 |
ENST00000576541.1
ENST00000576380.1 ENST00000571617.1 ENST00000576052.1 ENST00000576390.1 ENST00000573778.2 ENST00000439918.2 ENST00000574914.1 ENST00000331483.4 |
P4HB
|
prolyl 4-hydroxylase, beta polypeptide |
chr14_+_21249200 | 9.00 |
ENST00000304677.2
|
RNASE6
|
ribonuclease, RNase A family, k6 |
chr5_+_156696362 | 8.91 |
ENST00000377576.3
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
chr3_-_39321512 | 8.91 |
ENST00000399220.2
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1 |
chr21_-_38639813 | 8.90 |
ENST00000309117.6
ENST00000398998.1 |
DSCR3
|
Down syndrome critical region gene 3 |
chr19_+_3178736 | 8.89 |
ENST00000246115.3
|
S1PR4
|
sphingosine-1-phosphate receptor 4 |
chr15_+_81589254 | 8.89 |
ENST00000394652.2
|
IL16
|
interleukin 16 |
chr1_+_158801095 | 8.86 |
ENST00000368141.4
|
MNDA
|
myeloid cell nuclear differentiation antigen |
chr13_+_31191920 | 8.84 |
ENST00000255304.4
|
USPL1
|
ubiquitin specific peptidase like 1 |
chr4_-_926161 | 8.84 |
ENST00000511163.1
|
GAK
|
cyclin G associated kinase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.3 | 55.0 | GO:1902365 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
9.0 | 26.9 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
8.8 | 26.5 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
8.5 | 25.4 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
8.0 | 8.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
6.3 | 25.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
6.1 | 24.6 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
6.1 | 18.4 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
5.4 | 16.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
5.4 | 16.2 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
5.2 | 20.8 | GO:0002290 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
5.1 | 30.7 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
5.0 | 35.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
5.0 | 19.9 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
4.8 | 14.3 | GO:0039650 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
4.7 | 4.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
4.4 | 17.6 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
4.0 | 15.9 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
3.9 | 11.6 | GO:0034227 | tRNA thio-modification(GO:0034227) |
3.9 | 11.6 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
3.8 | 37.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
3.7 | 3.7 | GO:0009826 | unidimensional cell growth(GO:0009826) |
3.6 | 10.9 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
3.6 | 3.6 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
3.5 | 14.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
3.5 | 17.6 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
3.5 | 14.0 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
3.4 | 10.3 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
3.4 | 20.5 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
3.4 | 10.2 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
3.4 | 3.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
3.3 | 16.4 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) |
3.3 | 6.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
3.2 | 12.9 | GO:2000314 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
3.2 | 25.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
3.1 | 15.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
3.1 | 9.3 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
3.1 | 12.4 | GO:1904327 | maintenance of unfolded protein(GO:0036506) protein localization to cytosolic proteasome complex(GO:1904327) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
3.1 | 9.2 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
3.1 | 9.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
3.0 | 54.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
3.0 | 3.0 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
3.0 | 6.0 | GO:0070668 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
3.0 | 3.0 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
3.0 | 14.9 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
3.0 | 8.9 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
2.9 | 5.8 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
2.9 | 8.8 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
2.9 | 20.4 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
2.9 | 8.7 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
2.9 | 17.3 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
2.8 | 16.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
2.8 | 19.7 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
2.7 | 13.7 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
2.7 | 2.7 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
2.7 | 8.1 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) regulation of lactation(GO:1903487) |
2.7 | 10.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.6 | 7.9 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
2.6 | 7.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
2.6 | 2.6 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
2.6 | 7.8 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
2.6 | 7.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.6 | 12.8 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
2.6 | 2.6 | GO:0044010 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
2.5 | 10.1 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
2.5 | 2.5 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
2.5 | 17.3 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
2.4 | 12.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
2.4 | 21.4 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
2.4 | 14.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
2.4 | 11.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
2.4 | 4.7 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
2.4 | 7.1 | GO:1902769 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
2.4 | 16.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
2.3 | 21.1 | GO:0006531 | aspartate metabolic process(GO:0006531) |
2.3 | 6.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
2.3 | 36.2 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
2.2 | 6.7 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
2.2 | 15.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
2.2 | 8.8 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
2.2 | 26.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
2.2 | 15.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
2.2 | 10.9 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) bone marrow development(GO:0048539) |
2.2 | 6.5 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
2.2 | 6.5 | GO:1990502 | dense core granule maturation(GO:1990502) |
2.1 | 8.6 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) |
2.1 | 8.5 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
2.1 | 8.5 | GO:0019086 | late viral transcription(GO:0019086) |
2.1 | 8.4 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of hypersensitivity(GO:0002884) |
2.1 | 2.1 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
2.0 | 20.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
2.0 | 6.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
2.0 | 16.1 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
2.0 | 2.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
1.9 | 3.9 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
1.9 | 15.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.9 | 26.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.9 | 21.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
1.9 | 7.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.9 | 20.7 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
1.9 | 3.7 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
1.9 | 1.9 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.9 | 29.7 | GO:0045730 | respiratory burst(GO:0045730) |
1.9 | 3.7 | GO:0002384 | hepatic immune response(GO:0002384) |
1.8 | 3.7 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
1.8 | 34.4 | GO:0060117 | auditory receptor cell development(GO:0060117) |
1.8 | 5.3 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
1.8 | 19.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.8 | 5.3 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.8 | 10.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.7 | 26.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.7 | 5.2 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
1.7 | 5.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.7 | 13.8 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
1.7 | 20.6 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
1.7 | 8.6 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
1.7 | 25.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.7 | 5.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
1.7 | 25.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
1.7 | 25.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
1.7 | 5.0 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
1.7 | 3.4 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
1.7 | 10.0 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
1.7 | 3.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.7 | 8.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
1.7 | 6.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.6 | 9.9 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
1.6 | 4.9 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
1.6 | 4.9 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
1.6 | 1.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
1.6 | 4.8 | GO:0019417 | sulfur oxidation(GO:0019417) |
1.6 | 1.6 | GO:0051683 | Golgi localization(GO:0051645) establishment of Golgi localization(GO:0051683) |
1.6 | 9.6 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
1.6 | 3.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
1.6 | 4.8 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
1.6 | 7.9 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
1.6 | 4.7 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.6 | 3.2 | GO:0070426 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
1.6 | 24.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.5 | 3.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
1.5 | 4.5 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
1.5 | 4.5 | GO:0009078 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
1.5 | 6.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
1.5 | 13.4 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
1.5 | 11.7 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
1.5 | 4.4 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
1.4 | 11.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.4 | 4.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.4 | 1.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.4 | 2.9 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
1.4 | 14.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.4 | 1.4 | GO:1902532 | negative regulation of intracellular signal transduction(GO:1902532) |
1.4 | 23.6 | GO:0006265 | DNA topological change(GO:0006265) |
1.4 | 23.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.4 | 22.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.4 | 2.7 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
1.4 | 8.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
1.4 | 12.2 | GO:0045023 | G0 to G1 transition(GO:0045023) |
1.3 | 10.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.3 | 2.7 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
1.3 | 2.7 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.3 | 2.6 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.3 | 6.5 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
1.3 | 3.9 | GO:0035900 | response to isolation stress(GO:0035900) |
1.3 | 33.9 | GO:0071800 | podosome assembly(GO:0071800) |
1.3 | 3.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.3 | 9.0 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
1.3 | 5.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
1.3 | 10.2 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
1.3 | 10.2 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.3 | 12.7 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
1.3 | 3.8 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
1.3 | 6.3 | GO:2000843 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
1.3 | 15.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.2 | 5.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
1.2 | 2.5 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
1.2 | 7.5 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.2 | 3.7 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
1.2 | 2.4 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
1.2 | 9.7 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
1.2 | 9.7 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
1.2 | 6.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.2 | 2.4 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
1.2 | 2.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.2 | 3.5 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
1.2 | 1.2 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
1.2 | 1.2 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
1.2 | 25.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
1.2 | 7.0 | GO:0060613 | fat pad development(GO:0060613) |
1.2 | 3.5 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
1.2 | 11.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.1 | 2.3 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
1.1 | 16.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.1 | 3.4 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.1 | 4.5 | GO:0010193 | response to ozone(GO:0010193) |
1.1 | 7.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.1 | 5.6 | GO:0019835 | cytolysis(GO:0019835) |
1.1 | 4.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
1.1 | 3.4 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
1.1 | 4.4 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
1.1 | 5.5 | GO:1900920 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
1.1 | 5.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
1.1 | 8.8 | GO:0016926 | protein desumoylation(GO:0016926) |
1.1 | 11.0 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
1.1 | 3.3 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.1 | 3.3 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
1.1 | 11.0 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
1.1 | 4.4 | GO:0032053 | ciliary basal body organization(GO:0032053) |
1.1 | 8.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.1 | 7.6 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.1 | 6.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.1 | 7.6 | GO:0007000 | nucleolus organization(GO:0007000) |
1.1 | 4.3 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
1.1 | 4.2 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
1.1 | 11.6 | GO:0010224 | response to UV-B(GO:0010224) |
1.1 | 9.5 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
1.1 | 6.3 | GO:0097084 | establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) vascular smooth muscle cell development(GO:0097084) |
1.0 | 5.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
1.0 | 1.0 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
1.0 | 3.1 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
1.0 | 11.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
1.0 | 2.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.0 | 2.1 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
1.0 | 2.0 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
1.0 | 6.1 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
1.0 | 3.0 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
1.0 | 3.0 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
1.0 | 16.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.0 | 4.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.0 | 25.9 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
1.0 | 7.9 | GO:0042098 | T cell proliferation(GO:0042098) |
1.0 | 4.0 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
1.0 | 4.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
1.0 | 4.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
1.0 | 10.9 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
1.0 | 4.9 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
1.0 | 1.0 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
1.0 | 5.9 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
1.0 | 8.7 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.0 | 17.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.0 | 5.8 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
1.0 | 5.7 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
1.0 | 3.8 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
1.0 | 3.8 | GO:0035411 | catenin import into nucleus(GO:0035411) |
1.0 | 73.2 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.9 | 19.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.9 | 0.9 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.9 | 2.8 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.9 | 6.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.9 | 5.6 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.9 | 1.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.9 | 57.0 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.9 | 3.7 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.9 | 4.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.9 | 7.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.9 | 2.7 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.9 | 2.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.9 | 3.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.9 | 3.6 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.9 | 6.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.9 | 18.0 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.9 | 2.7 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.9 | 10.8 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.9 | 8.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.9 | 8.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.9 | 5.3 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.9 | 14.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.9 | 3.5 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.9 | 4.4 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.9 | 5.3 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.9 | 0.9 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.9 | 1.7 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.9 | 6.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.9 | 1.7 | GO:0086103 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.9 | 26.7 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.9 | 1.7 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.9 | 2.6 | GO:1901862 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle tissue development(GO:1901862) |
0.9 | 2.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.8 | 1.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.8 | 9.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.8 | 2.5 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
0.8 | 2.5 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.8 | 24.0 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.8 | 2.5 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.8 | 17.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.8 | 4.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.8 | 2.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.8 | 2.4 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.8 | 1.6 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.8 | 1.6 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.8 | 0.8 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.8 | 8.1 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.8 | 4.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.8 | 4.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.8 | 16.9 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.8 | 4.8 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.8 | 5.6 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
0.8 | 3.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.8 | 5.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.8 | 2.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.8 | 1.5 | GO:0035106 | operant conditioning(GO:0035106) |
0.8 | 1.5 | GO:0046636 | negative regulation of alpha-beta T cell activation(GO:0046636) |
0.8 | 4.6 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.8 | 1.5 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.8 | 6.0 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.8 | 2.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.8 | 6.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.7 | 3.7 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.7 | 2.2 | GO:0036507 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) endoplasmic reticulum mannose trimming(GO:1904380) |
0.7 | 2.2 | GO:1904616 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
0.7 | 7.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.7 | 2.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.7 | 4.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.7 | 5.1 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.7 | 5.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.7 | 1.5 | GO:0061010 | gall bladder development(GO:0061010) |
0.7 | 2.9 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.7 | 10.8 | GO:0050708 | regulation of protein secretion(GO:0050708) |
0.7 | 12.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.7 | 4.3 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.7 | 11.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.7 | 2.8 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.7 | 4.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.7 | 2.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.7 | 2.8 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.7 | 4.1 | GO:0045471 | response to ethanol(GO:0045471) |
0.7 | 4.8 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.7 | 3.4 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.7 | 9.5 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.7 | 20.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.7 | 0.7 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
0.7 | 6.0 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.7 | 8.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.7 | 6.7 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.7 | 6.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.7 | 3.3 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.7 | 17.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.7 | 0.7 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.7 | 3.9 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.7 | 1.3 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.7 | 1.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.6 | 32.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.6 | 2.6 | GO:0010813 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.6 | 4.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.6 | 1.3 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.6 | 3.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.6 | 3.9 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.6 | 10.9 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.6 | 1.3 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.6 | 3.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.6 | 12.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.6 | 1.9 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.6 | 2.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.6 | 3.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.6 | 1.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.6 | 1.9 | GO:2001245 | positive regulation of phospholipid biosynthetic process(GO:0071073) regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.6 | 5.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.6 | 18.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.6 | 2.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.6 | 7.5 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.6 | 3.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.6 | 2.5 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.6 | 27.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.6 | 3.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.6 | 1.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.6 | 6.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.6 | 31.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.6 | 3.0 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.6 | 1.2 | GO:0006568 | tryptophan metabolic process(GO:0006568) |
0.6 | 0.6 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.6 | 0.6 | GO:0090398 | cellular senescence(GO:0090398) |
0.6 | 1.8 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.6 | 14.2 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.6 | 8.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.6 | 3.0 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.6 | 2.4 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.6 | 1.2 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
0.6 | 19.5 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.6 | 2.9 | GO:0097338 | response to clozapine(GO:0097338) |
0.6 | 2.4 | GO:0018210 | peptidyl-threonine modification(GO:0018210) |
0.6 | 7.0 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.6 | 1.8 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.6 | 1.8 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.6 | 11.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.6 | 11.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.6 | 5.8 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.6 | 2.9 | GO:0044336 | embryonic genitalia morphogenesis(GO:0030538) canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.6 | 6.9 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.6 | 2.9 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.6 | 1.7 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.6 | 17.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.6 | 2.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.6 | 2.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.6 | 8.8 | GO:0018209 | peptidyl-serine modification(GO:0018209) |
0.5 | 15.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.5 | 1.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 1.1 | GO:0042109 | lymphotoxin A production(GO:0032641) interleukin-4 biosynthetic process(GO:0042097) lymphotoxin A biosynthetic process(GO:0042109) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.5 | 5.9 | GO:0033227 | dsRNA transport(GO:0033227) |
0.5 | 3.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.5 | 2.7 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.5 | 1.6 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.5 | 18.6 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.5 | 4.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 1.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.5 | 1.6 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.5 | 6.9 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.5 | 4.8 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.5 | 2.6 | GO:0070486 | leukocyte aggregation(GO:0070486) |
0.5 | 1.6 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.5 | 1.6 | GO:0001743 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
0.5 | 4.1 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.5 | 9.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.5 | 3.6 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.5 | 9.3 | GO:0042116 | macrophage activation(GO:0042116) |
0.5 | 0.5 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.5 | 4.1 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.5 | 2.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.5 | 6.1 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.5 | 7.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.5 | 1.5 | GO:1903028 | asymmetric Golgi ribbon formation(GO:0090164) positive regulation of opsonization(GO:1903028) |
0.5 | 9.7 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.5 | 1.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.5 | 2.5 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.5 | 3.5 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.5 | 3.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.5 | 7.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 10.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.5 | 3.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.5 | 2.0 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.5 | 11.9 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.5 | 4.0 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.5 | 0.5 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.5 | 8.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.5 | 2.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.5 | 2.0 | GO:0051693 | actin filament capping(GO:0051693) |
0.5 | 2.9 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
0.5 | 8.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.5 | 1.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.5 | 4.3 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.5 | 1.0 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.5 | 0.9 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.5 | 4.2 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.5 | 1.9 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.5 | 17.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.5 | 3.2 | GO:0032609 | interferon-gamma production(GO:0032609) |
0.5 | 8.8 | GO:0097576 | vacuole fusion(GO:0097576) |
0.5 | 9.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.5 | 4.1 | GO:1903275 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.5 | 2.3 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.5 | 1.8 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.5 | 10.0 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.5 | 1.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.5 | 0.9 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.4 | 3.1 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.4 | 9.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 0.4 | GO:0050955 | thermoception(GO:0050955) |
0.4 | 4.0 | GO:0048535 | lymph node development(GO:0048535) |
0.4 | 4.0 | GO:0014877 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.4 | 3.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.4 | 0.9 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
0.4 | 6.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.4 | 1.7 | GO:1901563 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
0.4 | 0.4 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.4 | 0.4 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.4 | 2.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.4 | 4.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 4.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 0.8 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
0.4 | 5.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 1.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.4 | 10.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.4 | 2.1 | GO:0002418 | immune response to tumor cell(GO:0002418) regulation of response to tumor cell(GO:0002834) regulation of immune response to tumor cell(GO:0002837) |
0.4 | 1.7 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 1.3 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.4 | 4.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.4 | 1.3 | GO:2000078 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) positive regulation of type B pancreatic cell development(GO:2000078) |
0.4 | 1.7 | GO:0097484 | dendrite extension(GO:0097484) |
0.4 | 1.7 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.4 | 5.0 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.4 | 0.4 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.4 | 0.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.4 | 2.0 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.4 | 0.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.4 | 7.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.4 | 1.6 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.4 | 1.2 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.4 | 3.6 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.4 | 1.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 0.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.4 | 1.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.4 | 10.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 1.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.4 | 4.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 3.5 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.4 | 6.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.4 | 1.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.4 | 2.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 5.0 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.4 | 1.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 47.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 1.9 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.4 | 1.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.4 | 1.9 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.4 | 3.8 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.4 | 1.9 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.4 | 4.5 | GO:0022038 | corpus callosum development(GO:0022038) |
0.4 | 1.5 | GO:0043335 | protein unfolding(GO:0043335) |
0.4 | 4.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.4 | 15.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.4 | 1.9 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.4 | 1.9 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.4 | 1.9 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.4 | 0.7 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.4 | 4.0 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.4 | 1.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.4 | 2.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.4 | 1.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 4.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.4 | 4.7 | GO:0036065 | fucosylation(GO:0036065) |
0.4 | 2.5 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.4 | 0.7 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.3 | 1.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 1.4 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.3 | 1.7 | GO:0042593 | carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
0.3 | 4.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.3 | 1.4 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.3 | 1.4 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.3 | 0.7 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.3 | 2.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.3 | 1.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.3 | 5.1 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.3 | 1.0 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.3 | 2.4 | GO:0045007 | depurination(GO:0045007) |
0.3 | 2.0 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.3 | 3.7 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.3 | 2.0 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.3 | 7.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 0.3 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.3 | 1.0 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.3 | 15.7 | GO:0006400 | tRNA modification(GO:0006400) |
0.3 | 4.2 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.3 | 1.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.3 | 1.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.3 | 2.9 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 8.1 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.3 | 3.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.3 | 1.0 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.3 | 0.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.6 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.3 | 4.1 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.3 | 12.7 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.3 | 0.6 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.3 | 6.0 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.3 | 1.9 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 2.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 2.8 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.3 | 2.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 4.6 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 14.5 | GO:0006906 | vesicle fusion(GO:0006906) |
0.3 | 5.7 | GO:0060325 | face morphogenesis(GO:0060325) |
0.3 | 6.0 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.3 | 5.4 | GO:0070206 | protein trimerization(GO:0070206) |
0.3 | 0.6 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.3 | 2.1 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.3 | 0.3 | GO:0045359 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.3 | 1.2 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.3 | 4.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.3 | 2.3 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.3 | 3.8 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.3 | 1.1 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
0.3 | 0.6 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.3 | 1.4 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 1.7 | GO:0070571 | negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 2.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.3 | 2.8 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 14.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.3 | 0.8 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.3 | 2.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.3 | 2.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.3 | 15.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.3 | 2.5 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.3 | 1.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 2.5 | GO:0009642 | response to light intensity(GO:0009642) |
0.3 | 0.8 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.3 | 0.8 | GO:1990834 | response to odorant(GO:1990834) |
0.3 | 3.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 1.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.3 | 1.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 6.5 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.3 | 1.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 2.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.3 | 1.6 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.3 | 8.8 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.3 | 6.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 1.3 | GO:0006041 | glucosamine metabolic process(GO:0006041) glucose 1-phosphate metabolic process(GO:0019255) |
0.3 | 2.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.3 | 0.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) fasciculation of motor neuron axon(GO:0097156) |
0.3 | 2.3 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.3 | 1.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 1.8 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.3 | 2.0 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 3.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.5 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.2 | 2.7 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.2 | 16.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 0.7 | GO:0032364 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
0.2 | 32.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 13.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 8.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.2 | 0.7 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.2 | 0.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.7 | GO:0050894 | determination of affect(GO:0050894) |
0.2 | 1.9 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.2 | 0.5 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.2 | 5.7 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.2 | 1.9 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
0.2 | 0.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 1.4 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.9 | GO:0030043 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) actin filament fragmentation(GO:0030043) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.2 | 1.4 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.2 | 2.5 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.2 | 0.9 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.2 | 2.4 | GO:0032869 | cellular response to insulin stimulus(GO:0032869) |
0.2 | 1.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 5.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 1.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 1.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 3.1 | GO:1904714 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.7 | GO:0003253 | neural crest cell migration involved in heart formation(GO:0003147) cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) cell migration involved in heart formation(GO:0060974) cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) anterior neural tube closure(GO:0061713) |
0.2 | 0.9 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 1.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 0.6 | GO:0033135 | regulation of peptidyl-serine phosphorylation(GO:0033135) |
0.2 | 0.6 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.2 | 0.6 | GO:0042698 | ovulation cycle(GO:0042698) |
0.2 | 2.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 1.9 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.2 | 2.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 2.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 2.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 2.2 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 2.0 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 0.6 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.2 | 0.4 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.2 | 1.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 0.8 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.2 | 0.8 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.2 | 9.5 | GO:0050776 | regulation of immune response(GO:0050776) |
0.2 | 0.2 | GO:0001763 | morphogenesis of a branching structure(GO:0001763) |
0.2 | 3.1 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.2 | 1.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.8 | GO:0019081 | viral translation(GO:0019081) viral translational termination-reinitiation(GO:0075525) |
0.2 | 1.0 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
0.2 | 0.8 | GO:0072660 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.2 | 0.6 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.2 | 6.3 | GO:0002279 | mast cell activation involved in immune response(GO:0002279) mast cell mediated immunity(GO:0002448) mast cell degranulation(GO:0043303) |
0.2 | 5.7 | GO:0009083 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 2.7 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.2 | 2.6 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.2 | 1.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 3.2 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.2 | 0.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.2 | 0.6 | GO:2001206 | positive regulation of bone development(GO:1903012) positive regulation of osteoclast development(GO:2001206) |
0.2 | 4.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 2.0 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.2 | 1.7 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 3.1 | GO:0048265 | response to pain(GO:0048265) |
0.2 | 3.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 11.8 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.2 | 4.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.7 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
0.2 | 3.9 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.2 | 1.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 2.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 2.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 2.6 | GO:0050890 | cognition(GO:0050890) |
0.2 | 0.9 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 4.8 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.2 | 0.9 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.3 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.2 | 0.5 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.2 | 0.8 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.2 | 1.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.8 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.2 | 3.0 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 0.5 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.2 | 3.9 | GO:1990090 | cellular response to nerve growth factor stimulus(GO:1990090) |
0.2 | 1.9 | GO:0003341 | cilium movement(GO:0003341) |
0.2 | 1.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 2.3 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.2 | 0.8 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 0.8 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.2 | 12.6 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 1.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 5.2 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.2 | 1.1 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.2 | 21.0 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 0.4 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 1.3 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 2.2 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.1 | 1.3 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 0.3 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.1 | 14.1 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 1.9 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.1 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.1 | 2.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 1.0 | GO:0042426 | choline catabolic process(GO:0042426) |
0.1 | 8.2 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.1 | 0.8 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.1 | 1.5 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 0.4 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.1 | 0.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 2.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.3 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 2.5 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.1 | 0.7 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.4 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 9.6 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
0.1 | 1.5 | GO:0042113 | B cell activation(GO:0042113) |
0.1 | 0.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 1.9 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.1 | 0.4 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.1 | 0.6 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.1 | 3.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.7 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 2.8 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 4.8 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 1.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 1.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 10.5 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 1.1 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 3.1 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.7 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 3.0 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 3.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.7 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.6 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 1.1 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.3 | GO:2000096 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 2.0 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.3 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 2.6 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 2.4 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.2 | GO:0044571 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) [2Fe-2S] cluster assembly(GO:0044571) |
0.1 | 0.8 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.1 | 0.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.9 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 2.1 | GO:0032608 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
0.1 | 4.1 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 1.4 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.8 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 1.2 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.8 | GO:0034765 | regulation of ion transmembrane transport(GO:0034765) |
0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 1.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 2.3 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.1 | 0.9 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 1.0 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.1 | 0.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 1.6 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.6 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 1.1 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.1 | 1.1 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.9 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.6 | GO:1900024 | regulation of substrate adhesion-dependent cell spreading(GO:1900024) positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 1.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.4 | GO:0051604 | protein maturation(GO:0051604) |
0.1 | 0.6 | GO:0046618 | drug export(GO:0046618) |
0.1 | 1.5 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.3 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 1.5 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 14.6 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.1 | 0.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 2.2 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.1 | 3.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.4 | GO:0035878 | nail development(GO:0035878) |
0.1 | 4.0 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.1 | 0.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 2.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.1 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.8 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.1 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.1 | 0.7 | GO:0034033 | coenzyme A metabolic process(GO:0015936) coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate metabolic process(GO:0033865) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate metabolic process(GO:0033875) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate metabolic process(GO:0034032) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 1.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 1.5 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.1 | 1.1 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.1 | 7.8 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.3 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 1.6 | GO:0050848 | regulation of calcium-mediated signaling(GO:0050848) |
0.1 | 1.1 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.1 | 2.3 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.1 | 0.4 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 0.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.9 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) central nervous system neuron axonogenesis(GO:0021955) |
0.1 | 0.4 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 3.2 | GO:0050870 | positive regulation of T cell activation(GO:0050870) |
0.1 | 1.2 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.7 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 1.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 3.4 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.1 | 0.5 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.1 | 1.2 | GO:0051592 | response to calcium ion(GO:0051592) |
0.1 | 0.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 1.3 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.6 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.1 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 | 1.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.4 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.0 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.5 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.6 | GO:0098760 | interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
0.0 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 1.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 1.0 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.5 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.0 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.0 | 0.4 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.6 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.0 | 0.8 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.5 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.6 | GO:0030282 | bone mineralization(GO:0030282) |
0.0 | 0.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.4 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.0 | 0.0 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.0 | 1.4 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.2 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.4 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.1 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.2 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.4 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.0 | 0.3 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.0 | 0.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.3 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.0 | 0.1 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.3 | 55.0 | GO:0061673 | cortical microtubule(GO:0055028) mitotic spindle astral microtubule(GO:0061673) |
14.1 | 84.5 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
6.6 | 19.9 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
6.0 | 30.0 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
5.2 | 57.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
5.0 | 14.9 | GO:0044609 | DBIRD complex(GO:0044609) |
4.7 | 18.6 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
4.7 | 14.0 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
4.1 | 32.5 | GO:0032010 | phagolysosome(GO:0032010) |
3.3 | 22.8 | GO:0072487 | MSL complex(GO:0072487) |
3.2 | 12.9 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
3.1 | 15.4 | GO:0070847 | core mediator complex(GO:0070847) |
3.0 | 9.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
2.9 | 20.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
2.9 | 20.6 | GO:0044194 | cytolytic granule(GO:0044194) |
2.9 | 11.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
2.9 | 66.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.7 | 10.9 | GO:1990745 | EARP complex(GO:1990745) |
2.4 | 4.8 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
2.4 | 2.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
2.4 | 50.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
2.3 | 9.4 | GO:0032059 | bleb(GO:0032059) |
2.2 | 8.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
2.1 | 6.3 | GO:0072563 | endothelial microparticle(GO:0072563) |
2.1 | 21.0 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
2.0 | 2.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
2.0 | 3.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
2.0 | 37.1 | GO:0001891 | phagocytic cup(GO:0001891) |
1.9 | 15.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.9 | 27.0 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
1.9 | 5.8 | GO:0019034 | viral replication complex(GO:0019034) |
1.9 | 13.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
1.9 | 13.4 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
1.9 | 7.6 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
1.8 | 1.8 | GO:0098536 | deuterosome(GO:0098536) |
1.8 | 9.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.8 | 9.1 | GO:0000801 | central element(GO:0000801) |
1.8 | 8.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
1.7 | 8.5 | GO:0089701 | U2AF(GO:0089701) |
1.7 | 13.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.7 | 11.9 | GO:0036021 | endolysosome lumen(GO:0036021) |
1.7 | 11.7 | GO:0033269 | internode region of axon(GO:0033269) |
1.6 | 8.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.6 | 4.8 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
1.5 | 5.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.5 | 4.4 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
1.5 | 8.8 | GO:1990130 | Iml1 complex(GO:1990130) |
1.4 | 9.9 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
1.4 | 6.9 | GO:0045298 | tubulin complex(GO:0045298) |
1.4 | 6.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.4 | 6.8 | GO:0032009 | early phagosome(GO:0032009) |
1.3 | 16.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.3 | 17.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.3 | 12.0 | GO:0032039 | integrator complex(GO:0032039) |
1.3 | 10.5 | GO:0035976 | AP1 complex(GO:0035976) |
1.3 | 5.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.3 | 2.6 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
1.3 | 3.8 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
1.2 | 6.0 | GO:0005602 | complement component C1 complex(GO:0005602) |
1.2 | 96.3 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
1.2 | 3.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.2 | 11.8 | GO:0097443 | sorting endosome(GO:0097443) |
1.2 | 20.9 | GO:0097342 | ripoptosome(GO:0097342) |
1.1 | 5.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.1 | 6.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.0 | 6.2 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
1.0 | 7.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.0 | 13.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.0 | 4.0 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.9 | 8.3 | GO:0030133 | transport vesicle(GO:0030133) |
0.9 | 3.6 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.9 | 6.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.9 | 10.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.9 | 2.7 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.9 | 18.9 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.9 | 7.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.9 | 20.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.9 | 5.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.9 | 11.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.9 | 6.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.8 | 5.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.8 | 2.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.8 | 47.2 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.8 | 4.9 | GO:1990037 | Lewy body core(GO:1990037) |
0.8 | 7.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.8 | 5.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.8 | 1.6 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.8 | 3.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.8 | 4.7 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.8 | 19.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.8 | 3.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.8 | 3.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.8 | 3.8 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.8 | 3.0 | GO:0055087 | Ski complex(GO:0055087) |
0.8 | 9.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.8 | 2.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.7 | 5.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.7 | 5.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.7 | 54.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.7 | 2.1 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.7 | 4.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.7 | 2.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.7 | 11.2 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.7 | 2.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.6 | 1.9 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
0.6 | 1.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.6 | 3.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.6 | 10.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.6 | 3.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.6 | 2.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.6 | 12.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.6 | 5.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 4.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.6 | 10.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.6 | 9.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.6 | 3.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.6 | 15.7 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.6 | 2.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 1.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.6 | 4.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.6 | 0.6 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.6 | 18.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.6 | 21.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.5 | 7.6 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.5 | 32.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.5 | 3.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.5 | 0.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.5 | 1.5 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.5 | 2.0 | GO:0097413 | Lewy body(GO:0097413) |
0.5 | 2.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.5 | 2.5 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.5 | 16.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 4.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.5 | 38.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.5 | 6.3 | GO:0008305 | integrin complex(GO:0008305) |
0.5 | 34.9 | GO:0035580 | specific granule lumen(GO:0035580) |
0.5 | 2.3 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.5 | 1.9 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.5 | 7.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.5 | 7.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.5 | 3.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.4 | 27.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.4 | 4.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 2.2 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.4 | 6.6 | GO:0000124 | SAGA complex(GO:0000124) |
0.4 | 2.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 3.0 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.4 | 5.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 6.5 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 4.7 | GO:0097433 | dense body(GO:0097433) |
0.4 | 4.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 4.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 21.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 4.9 | GO:0005642 | annulate lamellae(GO:0005642) |
0.4 | 5.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 12.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.4 | 7.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 2.0 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.4 | 2.8 | GO:0070938 | contractile ring(GO:0070938) |
0.4 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.4 | 5.1 | GO:0042599 | lamellar body(GO:0042599) |
0.4 | 1.6 | GO:0043293 | apoptosome(GO:0043293) |
0.4 | 5.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.4 | 2.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 0.8 | GO:0034657 | GID complex(GO:0034657) |
0.4 | 0.4 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 1.5 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.4 | 2.3 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.4 | 7.9 | GO:0043235 | receptor complex(GO:0043235) |
0.4 | 18.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.4 | 2.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.4 | 5.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.4 | 16.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.4 | 1.8 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.4 | 5.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 4.9 | GO:0033270 | paranode region of axon(GO:0033270) |
0.4 | 9.8 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 10.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.3 | 3.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.3 | 2.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 2.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 3.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 2.3 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 1.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 56.1 | GO:0030426 | growth cone(GO:0030426) |
0.3 | 1.7 | GO:0030427 | site of polarized growth(GO:0030427) |
0.3 | 16.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 12.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 2.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 1.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.3 | 4.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 3.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.3 | 72.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 2.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 7.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.3 | 6.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 6.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 19.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 8.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 5.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 0.9 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.3 | 1.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 2.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 10.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 1.4 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.3 | 11.8 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.3 | 1.0 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 4.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 2.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 1.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 40.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 0.7 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.2 | 1.7 | GO:0070187 | telosome(GO:0070187) |
0.2 | 5.8 | GO:0031904 | endosome lumen(GO:0031904) |
0.2 | 3.1 | GO:0005903 | brush border(GO:0005903) |
0.2 | 23.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 1.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.6 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 1.3 | GO:0033063 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 3.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 3.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 9.2 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 10.8 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.2 | 1.6 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 1.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 21.9 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 1.0 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 5.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 42.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 1.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 4.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 1.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.9 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 12.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 16.3 | GO:0005814 | centriole(GO:0005814) |
0.2 | 0.9 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.2 | 0.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.2 | 1.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 1.6 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.2 | 669.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.2 | 20.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 1.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.2 | 10.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 2.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 1.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 3.7 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 1.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 1.6 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.8 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.3 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 9.8 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 4.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 6.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.4 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 2.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 6.9 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.3 | GO:0043291 | RAVE complex(GO:0043291) |
0.1 | 4.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 5.0 | GO:0005768 | endosome(GO:0005768) |
0.1 | 2.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 1.9 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.1 | 1.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 86.4 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.5 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.1 | 0.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 1.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.9 | GO:0030135 | coated vesicle(GO:0030135) |
0.1 | 1.1 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 1.4 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 1.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.0 | GO:0098845 | postsynaptic recycling endosome(GO:0098837) postsynaptic endosome(GO:0098845) |
0.0 | 1.0 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 3.0 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.4 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 1.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.5 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 1.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.4 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 1.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 5.7 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.0 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 1.4 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.3 | 86.4 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
10.0 | 30.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
8.7 | 26.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
7.0 | 21.1 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
5.5 | 33.0 | GO:0042610 | CD8 receptor binding(GO:0042610) |
5.2 | 31.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
5.2 | 20.8 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
5.0 | 25.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
4.8 | 14.3 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
4.7 | 14.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
4.5 | 58.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
4.4 | 17.6 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
4.4 | 13.1 | GO:0032090 | Pyrin domain binding(GO:0032090) |
4.2 | 29.6 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
4.1 | 4.1 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
3.9 | 15.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
3.8 | 30.7 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
3.8 | 15.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
3.7 | 14.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
3.7 | 18.5 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
3.7 | 14.7 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
3.6 | 29.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
3.6 | 10.7 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
3.4 | 10.2 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
3.3 | 9.8 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
3.3 | 32.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
3.2 | 9.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
3.1 | 9.4 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
3.1 | 9.3 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
3.0 | 15.1 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
3.0 | 8.9 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
2.9 | 8.8 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
2.9 | 8.8 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
2.9 | 2.9 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
2.9 | 8.6 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
2.8 | 11.4 | GO:0005124 | scavenger receptor binding(GO:0005124) |
2.8 | 14.1 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
2.8 | 49.7 | GO:0005522 | profilin binding(GO:0005522) |
2.7 | 10.8 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
2.7 | 13.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
2.6 | 10.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
2.6 | 15.6 | GO:0003796 | lysozyme activity(GO:0003796) |
2.6 | 5.2 | GO:0030109 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) |
2.6 | 30.9 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
2.5 | 25.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.4 | 16.9 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
2.3 | 18.6 | GO:0043559 | insulin binding(GO:0043559) |
2.3 | 18.6 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
2.3 | 4.6 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
2.3 | 6.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
2.2 | 29.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
2.2 | 38.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
2.1 | 10.7 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
2.1 | 12.4 | GO:0003998 | acylphosphatase activity(GO:0003998) |
2.0 | 14.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
2.0 | 6.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
2.0 | 5.9 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
1.9 | 9.6 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
1.9 | 13.4 | GO:0097643 | amylin receptor activity(GO:0097643) |
1.9 | 5.7 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
1.9 | 7.5 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
1.9 | 11.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.9 | 3.7 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
1.8 | 3.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.8 | 12.8 | GO:0043426 | MRF binding(GO:0043426) |
1.8 | 9.0 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
1.7 | 8.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
1.7 | 8.5 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.7 | 11.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.7 | 21.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.7 | 6.6 | GO:0032810 | sterol response element binding(GO:0032810) |
1.6 | 6.5 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
1.6 | 11.3 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
1.6 | 43.4 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
1.6 | 9.6 | GO:0004522 | ribonuclease A activity(GO:0004522) |
1.6 | 39.8 | GO:0019865 | immunoglobulin binding(GO:0019865) |
1.6 | 3.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.6 | 19.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.6 | 4.7 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
1.5 | 36.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
1.5 | 6.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.5 | 3.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
1.5 | 29.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.4 | 11.5 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
1.4 | 4.3 | GO:0052596 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
1.4 | 4.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
1.4 | 4.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
1.4 | 5.6 | GO:0004803 | transposase activity(GO:0004803) |
1.4 | 20.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.4 | 6.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.4 | 6.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.4 | 15.0 | GO:0030274 | LIM domain binding(GO:0030274) |
1.4 | 16.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.3 | 28.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.3 | 5.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
1.3 | 7.9 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.3 | 6.5 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
1.3 | 3.9 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
1.3 | 18.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
1.3 | 23.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.3 | 11.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.3 | 3.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.3 | 2.5 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
1.3 | 18.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.2 | 3.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
1.2 | 9.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.2 | 3.7 | GO:1990405 | protein antigen binding(GO:1990405) |
1.2 | 6.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
1.2 | 2.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.1 | 4.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.1 | 7.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.1 | 5.7 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
1.1 | 3.4 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
1.1 | 1.1 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
1.1 | 3.3 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
1.1 | 14.4 | GO:0008199 | ferric iron binding(GO:0008199) |
1.1 | 5.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
1.1 | 8.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
1.1 | 3.3 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
1.1 | 19.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.1 | 18.5 | GO:0070513 | death domain binding(GO:0070513) |
1.1 | 26.1 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
1.1 | 18.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.1 | 7.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
1.1 | 4.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.0 | 16.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.0 | 6.1 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
1.0 | 26.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
1.0 | 4.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
1.0 | 11.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.0 | 3.0 | GO:0004320 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
1.0 | 4.0 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
1.0 | 12.0 | GO:0045159 | myosin II binding(GO:0045159) |
1.0 | 4.0 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
1.0 | 18.8 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
1.0 | 4.8 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
1.0 | 9.6 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.0 | 16.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.9 | 5.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.9 | 9.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.9 | 2.7 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.9 | 6.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.9 | 14.4 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.9 | 2.6 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.9 | 0.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.9 | 2.6 | GO:0015267 | channel activity(GO:0015267) passive transmembrane transporter activity(GO:0022803) |
0.9 | 4.3 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.9 | 3.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.9 | 14.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.9 | 15.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.8 | 2.5 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.8 | 6.7 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.8 | 1.7 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.8 | 3.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.8 | 4.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.8 | 3.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.8 | 8.1 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.8 | 18.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.8 | 8.8 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.8 | 4.0 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.8 | 2.4 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.8 | 2.3 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
0.8 | 2.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) steroid delta-isomerase activity(GO:0004769) |
0.8 | 73.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.8 | 7.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.8 | 10.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.8 | 29.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.8 | 19.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.8 | 2.3 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.8 | 6.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.8 | 30.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.8 | 4.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.7 | 2.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.7 | 76.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.7 | 0.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.7 | 2.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.7 | 2.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.7 | 2.9 | GO:0016160 | amylase activity(GO:0016160) maltose alpha-glucosidase activity(GO:0032450) |
0.7 | 32.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.7 | 8.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) bioactive lipid receptor activity(GO:0045125) |
0.7 | 5.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.7 | 3.6 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.7 | 2.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.7 | 11.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.7 | 5.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.7 | 5.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.7 | 2.1 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.7 | 2.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.7 | 5.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.7 | 2.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
0.7 | 5.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.7 | 18.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.7 | 10.2 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.7 | 2.7 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.7 | 2.0 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.7 | 2.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.7 | 2.0 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.7 | 2.7 | GO:0030305 | beta-glucuronidase activity(GO:0004566) heparanase activity(GO:0030305) |
0.7 | 3.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.6 | 44.7 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.6 | 1.9 | GO:0004040 | amidase activity(GO:0004040) |
0.6 | 1.9 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.6 | 1.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.6 | 17.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.6 | 6.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.6 | 1.9 | GO:0070538 | oleic acid binding(GO:0070538) |
0.6 | 10.0 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.6 | 1.9 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.6 | 1.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.6 | 3.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.6 | 4.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.6 | 2.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.6 | 15.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.6 | 2.4 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.6 | 1.8 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.6 | 9.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.6 | 27.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.6 | 2.4 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.6 | 7.6 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.6 | 2.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.6 | 7.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.6 | 4.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 4.0 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.6 | 5.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.6 | 1.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.6 | 34.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.6 | 6.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.6 | 2.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.6 | 10.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.5 | 23.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.5 | 8.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.5 | 5.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.5 | 12.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.5 | 2.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.5 | 2.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.5 | 1.5 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.5 | 10.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.5 | 2.0 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.5 | 3.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.5 | 2.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 2.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.5 | 0.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.5 | 2.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.5 | 3.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.5 | 12.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 6.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.5 | 6.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 2.4 | GO:0089720 | caspase binding(GO:0089720) |
0.5 | 2.8 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.5 | 2.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.5 | 1.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 1.4 | GO:0004797 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
0.5 | 3.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.5 | 15.0 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.4 | 4.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 9.9 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.4 | 5.4 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.4 | 5.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 0.9 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.4 | 2.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 3.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 6.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.4 | 4.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.4 | 0.9 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.4 | 2.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.4 | 1.3 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.4 | 0.9 | GO:0035673 | oligopeptide transporter activity(GO:0015198) oligopeptide transmembrane transporter activity(GO:0035673) |
0.4 | 1.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.4 | 6.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 5.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 2.6 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.4 | 1.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.4 | 4.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.4 | 3.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 51.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.4 | 4.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.4 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 1.3 | GO:0016731 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
0.4 | 3.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.4 | 57.0 | GO:0005178 | integrin binding(GO:0005178) |
0.4 | 1.7 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.4 | 2.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.4 | 2.0 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.4 | 3.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 4.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 2.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 1.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 3.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.4 | 5.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.4 | 19.2 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.4 | 11.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.4 | 1.5 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.4 | 1.5 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.4 | 2.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 3.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 5.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 1.9 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.4 | 16.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.4 | 3.7 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.4 | 18.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.4 | 5.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.4 | 5.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 2.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.4 | 1.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 4.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.4 | 10.2 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.4 | 1.8 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.3 | 9.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 1.4 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.3 | 0.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.3 | 7.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 16.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.3 | 5.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 1.3 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.3 | 2.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 2.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 4.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 1.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 2.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 1.6 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.3 | 3.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 5.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 16.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 8.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.3 | 1.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 50.4 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.3 | 1.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 0.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.3 | 2.7 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.3 | 0.6 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.3 | 13.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 1.2 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.3 | 0.9 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.3 | 2.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.3 | 3.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 0.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 1.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 3.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 3.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.3 | 2.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 1.4 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.3 | 2.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 4.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 15.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 1.7 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 0.8 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 9.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 4.1 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.3 | 7.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 1.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.3 | 1.1 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.3 | 1.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 6.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.3 | 1.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 4.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 2.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 1.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 3.9 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 13.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 0.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 1.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 1.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 5.8 | GO:0061733 | histone acetyltransferase activity(GO:0004402) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 3.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 61.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.2 | 20.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 1.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 3.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 1.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.2 | 0.9 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 1.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 0.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 1.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 23.7 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 0.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 2.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 1.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.2 | 4.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.8 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.2 | 1.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 1.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 1.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 12.5 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.2 | 4.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 5.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 1.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 1.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 4.4 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.2 | 4.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 1.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.7 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.2 | 10.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 1.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.2 | 2.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 40.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 0.7 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.2 | 0.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 0.8 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 1.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 2.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 5.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 2.8 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 0.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 3.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 1.7 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 2.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 2.5 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.1 | 1.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 4.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 3.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.7 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.1 | 136.4 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 2.3 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.1 | 4.9 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 2.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 1.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.7 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 1.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 1.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.5 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 2.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 26.4 | GO:0008236 | serine-type peptidase activity(GO:0008236) serine hydrolase activity(GO:0017171) |
0.1 | 1.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 1.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 2.7 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 1.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.6 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 3.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 1.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.4 | GO:0016841 | carbon-nitrogen lyase activity(GO:0016840) ammonia-lyase activity(GO:0016841) |
0.1 | 0.9 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 1.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.2 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.1 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.1 | 1.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 1.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 2.2 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.1 | 2.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 1.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 0.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.9 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.5 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 2.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 1.7 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 3.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 1.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 3.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 2.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 2.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 48.9 | GO:0060089 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.1 | 5.0 | GO:0008233 | peptidase activity(GO:0008233) |
0.1 | 1.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 2.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 1.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 3.5 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.1 | 1.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.9 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 1.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.0 | GO:0003909 | DNA ligase activity(GO:0003909) |
0.0 | 0.4 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.2 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.6 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 0.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 3.2 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 1.1 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 1.2 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 176.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.1 | 189.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
2.0 | 49.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.9 | 57.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.7 | 24.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.7 | 112.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.1 | 7.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.1 | 2.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.1 | 81.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.0 | 31.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.0 | 29.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.0 | 2.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.0 | 34.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.9 | 66.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.9 | 23.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.9 | 5.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.8 | 15.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.8 | 2.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.8 | 20.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.8 | 16.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.7 | 24.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.7 | 16.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.7 | 32.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.7 | 18.7 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.7 | 24.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.7 | 21.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.7 | 9.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.7 | 2.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.6 | 11.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.6 | 47.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.6 | 11.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.6 | 2.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.6 | 2.9 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.6 | 2.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.5 | 2.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 66.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.5 | 23.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 12.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.5 | 19.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 16.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.5 | 10.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 116.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.4 | 9.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.4 | 4.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.4 | 3.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 63.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 11.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 15.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 7.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 13.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 7.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 10.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 1.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 3.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 6.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 3.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 11.9 | PID ATM PATHWAY | ATM pathway |
0.2 | 2.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 4.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 73.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 9.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 10.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 2.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 2.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 2.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 5.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 3.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 9.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 36.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 6.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 3.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 6.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 7.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 2.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 2.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 2.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.3 | PID FGF PATHWAY | FGF signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 25.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
4.7 | 122.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
4.6 | 27.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
3.4 | 10.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
3.1 | 275.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
2.9 | 43.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.9 | 40.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.9 | 62.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.7 | 27.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
1.5 | 20.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
1.4 | 11.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.4 | 4.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.4 | 16.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
1.4 | 31.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.3 | 24.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.2 | 8.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.1 | 19.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.1 | 20.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.1 | 39.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.0 | 18.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.0 | 18.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.9 | 40.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.9 | 15.0 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.9 | 38.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.9 | 14.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.8 | 12.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.8 | 133.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.8 | 36.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.8 | 38.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.8 | 1.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.8 | 3.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.8 | 16.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.7 | 21.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.7 | 26.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.7 | 2.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.7 | 14.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.7 | 10.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.6 | 39.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.6 | 12.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.6 | 8.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.6 | 14.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.6 | 6.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.6 | 6.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.6 | 6.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.6 | 36.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.6 | 5.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.5 | 6.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 37.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.5 | 9.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.5 | 1.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.5 | 5.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.5 | 5.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 4.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.5 | 8.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.5 | 24.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.5 | 2.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 5.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.4 | 12.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.4 | 22.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 14.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 41.6 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.4 | 4.7 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 5.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 14.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.4 | 61.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 8.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 1.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 14.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.4 | 7.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 0.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 4.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 4.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.3 | 8.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 51.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.3 | 13.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 13.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 4.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 11.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.3 | 2.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 7.4 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.3 | 14.0 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.3 | 1.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.3 | 24.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 2.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.3 | 1.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 5.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 4.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 5.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 0.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 3.9 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 3.5 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.2 | 4.9 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.2 | 22.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 4.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 23.1 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 5.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 6.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 3.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 2.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 56.8 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.2 | 3.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 3.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 3.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 2.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 1.7 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 3.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 1.5 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.2 | 0.9 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.2 | 3.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 6.5 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 1.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 2.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 7.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.7 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 4.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 8.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 11.0 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 2.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 3.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 11.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 2.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 0.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 1.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 3.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 2.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 2.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.2 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.1 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 4.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 2.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 1.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 1.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 1.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |